Research Wire

A study led by William H. McCoy IV, MD, PhD, an assistant professor of medicine in the Division of Dermatology at WashU Medicine, has identified an important way that Cutibacterium acnes bacteria thrives on human skin.

Joe Loewenstein, a professor of English​ and director of the Humanities Digital Workshop and the Interdisciplinary Project in the Humanities, all in Arts & Sciences, will serve as co-principal investigator for a $798,000 Human Networks and Data Science grant from the National Science Foundation.

Scientists at WashU Medicine have identified unexpected functions of a key gene known for blood cell formation. When mutated, the gene, DNMT3A, may contribute in previously unknown ways to blood cancers.

Researchers at Washington University in St. Louis have received a National Science Foundation grant to use artificial intelligence to design a new kind of plastics that can be easily broken down and recycled.

Researchers at WashU Medicine have developed the first mouse model to replicate the disrupted sleep patterns seen in people with chronic pain.

Alexandra Rutz, a biomedical engineer at WashU, has received a CAREER Award from the National Science Foundation to create 3D bioelectronic scaffolds for ovarian follicles, to be used for infertility and aging research.

Environmental engineer Jenna Ditto, at WashU, aims to establish a link between indoor air quality and the chemistry of building material surfaces with a grant from the National Science Foundation.

WashU Medicine researchers led by Alex Holehouse have developed a novel method of predicting how certain hard-to-study proteins will behave, with potential implications for research and treatment of many diseases.

A new study in mice by WashU Medicine researchers identifies a possible strategy for cardiac immunotherapy that could boost beneficial immune cells that, surprisingly, travel from the spleen to the heart and orchestrate healing after a heart attack.

A new study from WashU Medicine researchers identifies possible ways to make cancer drugs called PARP inhibitors more effective, including potential strategies to re-establish their effectiveness in tumors that develop resistance to this treatment.